Article Text

PDF

GW23-e0110
EFFECTS OF FISH OIL SUPPLEMENTATION ON INFLAMMATORY MARKERS IN CHRONIC HEART FAILURE: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
  1. Xin Wei,
  2. Li Xiaoying
  1. Chinese PLA General Hospital

    Abstract

    Objectives Effects of additional fish oil supplementation on systematic inflammation in patients with chronic heart failure (CHF) remain controversial. We performed a meta-analysis to evaluate effects of oral fish oil intake on circulating levels of inflammatory markers in patients with CHF.

    Methods Human intervention studies evaluating fish oil supplementation in CHF patients were identified by systematic search of Medline, Embase, Cochrane's library and references cited in related reviews and studies through November 2011. Either a fixed-effect model or, in the presence of heterogeneity, a random-effect model was used to estimate the combined effects.

    Results A total of seven trials were reviewed. Meta-analysis results showed circulating levels of tumour necrosis factor α (SMD=−0.62, 95% CI −1.08 to −0.16, p=0.009), interleukin 1 (SMD=−1.24, 95% CI −1.56 to −0.91, p<0.001) and interleukin 6 (SMD=−0.81, 95% CI −1.48 to −0.14, p=0.02) were significantly reduced in fish oil group compared with placebo; however, circulating levels of high sensitivity C reactive protein (SMD=−0.02, 95% CI −0.26 to 0.21, p=0.84), soluble intracellular adhesion molecular 1 (SMD=−0.19, 95% CI −0.97 to 0.58, p=0.63) and vascular cell adhesion molecular 1 (SMD=−0.06, 95% CI −0.33 to 0.21, p=0.65) remained unchanged. Meta-regression and subgroup analysis indicated the differences in dose of fish oil and follow-up duration might influence the effects of fish oil on the inflammatory markers significantly. Greater reduction of these inflammatory markers might be identified in patients taken higher dose of fish oil (over 1000 mg/day) for a longer duration (over 4 months).

    Conclusions Anti-inflammation may be a possible mechanism underlying the potential therapeutic role of fish oil for patients with CHF who were already on current optimal medications. These effects seem to be more remarkable in patients who took fish oil in a higher dose and for a longer duration.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.